Hongxia Zheng

Hongxia Zheng is an experienced medical executive currently serving as Chief Medical Officer at Fapon since May 2023. Previously, Hongxia held the same title at Abogenbio from July 2021 to April 2023 and served as SVP of Clinical Development at JW Therapeutics from February 2019 to July 2021. Additional roles include Chief Medical Officer at Biosense and Global Clinical Leader in Oncology at Bayer HealthCare. Hongxia Zheng holds a Ph.D. in Pharmacology from the University of Pittsburgh and an MD in Medicine from Capital University of Medical Sciences.